Quality of life with cediranib in relapsed ovarian cancer: The ICON6 phase 3 randomized clinical trial. (2017)

First Author: Stark DP
Attributed to:  CANCER: Trials with potential global reach and other challenging trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/cncr.30657

PubMed Identifier: 28339098

Publication URI: http://europepmc.org/abstract/MED/28339098

Type: Journal Article/Review

Volume: 123

Parent Publication: Cancer

Issue: 14

ISSN: 0008-543X